| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000034495 |
| Receipt No. | R000039117 |
| Scientific Title | Prospective randomized single center study on sibling fertilized oocytes comparing a single step culture media system with antioxidants (Gx-TL) versus a one-drop sequential culture media system with antioxidants (Gx-1, Gx-ODS) |
| Date of disclosure of the study information | 2018/10/17 |
| Last modified on | 2022/04/18 (Ver. 3) |
| Basic information | ||
| Public title | Prospective randomized single center study on sibling fertilized oocytes comparing a single step culture media system with antioxidants (Gx-TL) versus a one-drop sequential culture media system with antioxidants (Gx-1, Gx-ODS) | |
| Acronym | Culture in single step media versus one drop sequential culture media | |
| Scientific Title | Prospective randomized single center study on sibling fertilized oocytes comparing a single step culture media system with antioxidants (Gx-TL) versus a one-drop sequential culture media system with antioxidants (Gx-1, Gx-ODS) | |
| Scientific Title:Acronym | Culture in single step media versus one drop sequential culture media | |
| Region |
|
|
| Condition | ||
| Condition | Infertility | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The primary objective of this investigation is to assess blastocyst development comparing a single step culture media Gx-TL with the investigational devices Gx-1 and Gx-ODS. |
| Basic objectives2 | Others |
| Basic objectives -Others | Secondary objectives are to compare other developmental characteristics of embryos at different points of development by either using classic morphological assessment or by using time-lapse technology as well as outcome after embryo replacement. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary endpoint of the investigation is blastocyst formation on day 5 per allocated normally fertilized oocyte. |
| Key secondary outcomes | Secondary endpoints are:
- Embryo development day 3 - Embryo quality day 3 - Embryo development day 5 - Embryo quality day 5 - Embryo development day 6 - Embryo quality day 6 - Total blastocyst formation (day 5 and day 6) - Utilization rate (embryos available for replacement and cryopreservation) - Clinical pregnancy rate - Implantation rate |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | One-drop sequential culture media system | |
| Interventions/Control_2 | single step culture media system | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Women coming for fertility treatment presenting with more than 6 normally fertilized oocytes at the time of fertilization assessment except for the exclusion criteria listed below.
Having signed the study-specific consent form at the time of oocyte retrieval. |
|||
| Key exclusion criteria | Surgically retrieved sperm cells.
more than 30 normally fertilized oocytes. Normal fertilization rate less than 40 percent. Less than 6 fertilized oocytes on day 1. Split IVF. |
|||
| Target sample size | 128 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyono ART Clinic | ||||||
| Division name | President | ||||||
| Zip code | |||||||
| Address | 1-1-1 3F, Honcho Aobaku,Sendai, Miyagi 980 0014, JAPAN | ||||||
| TEL | 022-722-5991 | ||||||
| rec-sec@ivf-kyono.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyono ART Clinic | ||||||
| Division name | Labolatory | ||||||
| Zip code | |||||||
| Address | 1-1-1 3F, Honcho Aobaku,Sendai, Miyagi 980 0014, JAPAN | ||||||
| TEL | 022-722-5991 | ||||||
| Homepage URL | |||||||
| aono@ivf-kyono.or.jp | |||||||
| Sponsor | |
| Institute | Vitrolife Sweden AB |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039117 |